A Partial Approval for Amgen’s Osteoporosis Drug

Thursday, August 13, 2009 - 22:42 in Health & Medicine

The new drug, the company’s best hope for future growth, won a partial endorsement from a federal advisory committee despite concerns about the product’s safety.

Read the whole article on NY Times Health

More from NY Times Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net